SANTA FE, N.M., April 05, 2017 -- Sigma Labs, Inc. (NASDAQ:SGLB) (“Sigma Labs” or the “Company”), a provider of quality assurance software under the PrintRite3D® brand, today announced the release of its OEM Developer's Kit for PrintRite3D® INSPECT™ quality assurance software version 2.0. The Company has placed its alpha version of the OEM Developer's Kit with a European OEM partner for immediate evaluation and incorporation into its 3D printers. The Developer's Kit allows an OEM to seamlessly and quickly embed PrintRite3D® technology directly into their products, speeding their product launch, rapidly reaching customers and achieving a competitive advantage.
“We are proud to announce that our OEM Developer's Kit for INSPECT™ 2.0 web-based software has been placed with one of our European OEM partners for immediate evaluation,” said Mark Cola, President and CEO of Sigma Labs. “Our PrintRite3D® INSPECT™ OEM Developer's Kit is customizable and features an intuitive graphical user interface, and web-based REST API which provides the architecture and framework for Industrial Internet of Things (IoT) edge computing applications. We are excited to be able to offer our OEM Partners this latest Industry 4.0 manufacturing technology and believe Sigma Labs can help our OEM Partners build a precompetitive advantage for Edge Intelligence for Industrial and Commercial IoT.”
Additional product information is available on Sigma Labs’ website at www.sigmalabsinc.com.
About Sigma Labs, Inc.
Sigma Labs, Inc. is a provider of quality assurance software under the PrintRite3D® brand and a developer of advanced, in-process, non-destructive quality assurance software for commercial firms worldwide seeking productive solutions for advanced manufacturing. For more information please visit us at www.sigmalabsinc.com.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project,” “prospects,” “outlook,” and similar words or expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could” are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company's actual results, performance or achievements to be materially different from any anticipated results, performance or achievements. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional risks and uncertainties that could impact the Company’s forward-looking statements, please see the Company’s Annual Report on Form 10-K (including but not limited to the discussion under “Risk Factors” therein) filed with the SEC on March 31, 2017 and which may be viewed at http://www.sec.gov.
Investor Relations Contact: Scott Gordon [email protected] 631-703-4900


BlackRock to Cut Around 250 Jobs as CEO Larry Fink Pushes Strategic Shift
Taiwan Issues Arrest Warrant for OnePlus CEO Over Alleged Illegal Recruitment Activities
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
AFT Leaves X Over AI-Generated Images of Minors
Alphabet Stock Poised for Growth as Bank of America Sees Strong AI Momentum Into 2026
U.S. Lawmakers Raise Alarm Over Trump Approval of Nvidia AI Chip Sales to China
SK Hynix to Invest $13 Billion in Advanced Chip Packaging Plant as AI Memory Demand Surges
Zhipu AI Launches GLM-Image Model Trained on Huawei Chips, Boosting China’s AI Self-Reliance Drive
Rio Tinto and BHP Agree to Explore Major Iron Ore Collaboration in Pilbara
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
Trump Administration Approves Nvidia H200 AI Chip Sales to China Under New Export Rules
AbbVie Commits $100 Billion to U.S. Investment in Drug Pricing Deal With Trump Administration
Microsoft Strikes Landmark Soil Carbon Credit Deal With Indigo Carbon to Boost Carbon-Negative Goal
Tesla, EEOC Move Toward Mediation in Racial Harassment Lawsuit
Coca-Cola Shelves Costa Coffee Sale After Low Private Equity Offers
Nvidia Denies Upfront Payment Requirement for H200 AI Chips Amid China Export Scrutiny 



